Drug intelligence / Profile preview

iSCLife X

Development stage
Preclinical
Lead developer
Sclnow Biotechnology
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intravenous
01

Overview

iSCLife X (also known as D759389) is an allogeneic umbilical cord-derived mesenchymal stem cell (UC-MSC) therapy developed by Sclnow Biotechnology (SCLnow) specifically for anti-aging and tissue restoration applications. The product utilizes pluripotent stem cells derived from neonatal umbilical cord tissue, which are stored in cryopreservant at -196°C in liquid nitrogen. The therapy works through mechanisms of migration tropism and pluripotency to activate dormant stem cell populations throughout the body and replace degenerated or aging cells. By restoring tissue and organ function and improving cellular communication that typically deteriorates with age, the treatment aims to enhance tissue activity and tolerance. It is administered as an intravenous drip preparation.

Brand names
iSCLife X
Other names
iSCLife®XiSCLife X-Sclnow Biotechnology-cell therapy-stem cell therapy-Anti-aging-tissue restoration

Beyond the preview

Go deeper on iSCLife X.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on iSCLife X.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call